Commenting on FDA’s 503B wholesaling draft GFI

Hey 503As, we’ve already asked our 503Bs; now we need your help in determining the substance of APC's comments on FDA’s draft guidance on 503B wholesaling. We’ll be submitting our comment letter later this month.

Please take this short survey by August 14.

This week, FDA published a new draft guidance on the Prohibition on Wholesaling Under Section 503B...

We reported last week that FDA had issued guidance on 503B wholesaling. Now, the agency has...

STOP THE PRESSES! Earlier this week, the FDA released its final interim guidance for compounding...

Commenting on FDA’s 503B wholesaling draft GFI

Related posts

FDA issues draft guidance on 503B wholesaling

FDA briefing on 503B guidance draft

FDA releases final interim guidance on bulk drug substances for both 503As and 503Bs